Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-022863

Director sold 8,904 shares at $40.00 ($356,171)

  • Director acquired 8,904 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tsuchimoto Kim R Director 2025-07-14 Option exercise +8,904 $0.01 $45 20,390 D
Tsuchimoto Kim R Director 2025-07-14 Sale −8,904 $40.00 $356,171 11,486 D
Derivatives
Tsuchimoto Kim R Director 2025-07-14 Option exercise · Stock Options −4,200 0 D
Tsuchimoto Kim R Director 2025-07-14 Option exercise · Stock Options −4,704 0 D
Open-market sales · 8,904 sh · avg $40.00 · $356,171
Loading xslF345X05/rdgdoc.xml…